Close

UPDATE: Leerink Partners Downgrades Intra-Cellular Therapies (ITCI) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. CMG


Go back to UPDATE: Leerink Partners Downgrades Intra-Cellular Therapies (ITCI) to Market Perform
INTRA-CELL THRP (NASDAQ: ITCI) Delayed: 73.12 --0 (-0%)
Previous Close $73.12    52 Week High $59.96 
Open $73.12    52 Week Low $10.80 
Day High $73.12    P/E N/A 
Day Low $73.12    EPS $0.00 
Volume 1,320